Exagen Inc. (XGN) SEC Filings — 2024
16 SEC filings for Exagen Inc. (XGN) in 2024.
Filings
- Exagen Inc. SC 13G/A Filing — SC 13G/A · Dec 12, 2024
- Exagen Inc. Files Q3 2024 10-Q Report — 10-Q · Nov 12, 2024
- Exagen Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 5, 2024
- Exagen Inc. Amends Filing on Director Changes and Officer Compensation — 8-K/A · Aug 2, 2024
- Exagen Inc. Files 8-K on Shareholder Vote Matters — 8-K · Jun 11, 2024
- Exagen Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Exagen Appoints Dr. Dennis Horvath as CEO — 8-K · Apr 26, 2024
- Exagen Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 18, 2024
- Exagen Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Exagen Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Exagen Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Exagen Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Wasatch Advisors LP Cuts Exagen Stake to 4.9% — SC 13G/A · Feb 9, 2024
- Cowen Financial Products Reports 898,630 Share Stake in Exagen Inc. — SC 13G/A · Feb 2, 2024
- NMSIC Co-Investment Fund Updates Exagen Stake; Shifts Reporting Status — SC 13G/A · Jan 22, 2024
- EXAGEN Files 8-K on Financial Condition, Operations — 8-K · Jan 8, 2024